We are live on ! Find out more
KRYS icon

Krystal Biotech
KRYS

108 hedge funds and large institutions have $836M invested in Krystal Biotech in 2020 Q4 according to their latest regulatory filings, with 20 funds opening new positions, 35 increasing their positions, 31 reducing their positions, and 10 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more first-time investments, than exits

New positions opened: 20 | Existing positions closed: 10

34% more capital invested

Capital invested by funds: $623M → $836M (+$213M)

13% more repeat investments, than reductions

Existing positions increased: 35 | Existing positions reduced: 31

10% more funds holding

Funds holding: 98 → 108 (+10)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

2.88% less ownership

Funds ownership: 73.48% → 70.6% (-2.9%)

Holders
108
Holders Change
+10
Holders Change %
+10.2%
% of All Funds
1.91%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
20
Increased
35
Reduced
31
Closed
10
Calls
$2.53M
Puts
–
Net Calls
+$2.53M
Net Calls Change
+$3.58M

Top Buyers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
+$10.5M
2
Fidelity International
Fidelity International
Bermuda
+$9.01M
3
RG
Redmile Group
California
+$8.64M
4
JP Morgan Chase
JP Morgan Chase
New York
+$7.67M
5
DP
DSAM Partners
United Kingdom
+$4.38M

Top Sellers

Rank Fund Capital Flow
1
Victory Capital Management
Victory Capital Management
Texas
-$22.6M
2
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
-$20.8M
3
Point72 Asset Management
Point72 Asset Management
Connecticut
-$8.18M
4
SFM
Sphera Funds Management
Israel
-$4.17M
5
Fidelity Investments
Fidelity Investments
Massachusetts
-$3.84M
Name Holding Trade Value Shares
Change 		Change in
Stake
Handelsbanken Fonder
26
Handelsbanken Fonder
Sweden
$5.4M – – –
DP
27
DSAM Partners
United Kingdom
$5.26M +$4.38M +87,608 New
SST
28
S Squared Technology
New York
$5.11M +$250K +5,000 +6%
Verition Fund Management
29
Verition Fund Management
Connecticut
$4.65M +$1.07M +21,515 +38%
Carson Wealth (CWM LLC)
30
Carson Wealth (CWM LLC)
Nebraska
$4.22M – – –
Dimensional Fund Advisors
31
Dimensional Fund Advisors
Texas
$4.1M +$1.07M +21,390 +46%
Bank of New York Mellon
32
Bank of New York Mellon
New York
$4.05M +$253K +5,065 +8%
Neuberger Berman Group
33
Neuberger Berman Group
New York
$3.06M – – –
N
34
Nuveen
North Carolina
$2.89M +$60.8K +1,217 +3%
SG Americas Securities
35
SG Americas Securities
New York
$2.58M -$694K -13,891 -24%
Vontobel Holding
36
Vontobel Holding
Switzerland
$2.19M +$1.82M +36,448 New
AA
37
ALPS Advisors
Colorado
$2.13M +$523K +10,467 +42%
William Blair & Company
38
William Blair & Company
Illinois
$2.12M -$38K -761 -2%
MOACM
39
Mutual of America Capital Management
New York
$2.04M +$250K +5,006 +17%
Aviva
40
Aviva
United Kingdom
$1.75M -$1.18M -23,584 -45%
Swiss National Bank
41
Swiss National Bank
Switzerland
$1.73M – – –
Citadel Advisors
42
Citadel Advisors
Florida
$1.72M +$224K +4,484 +19%
California Public Employees Retirement System
43
California Public Employees Retirement System
California
$1.65M -$65.3K -1,308 -5%
BBHC
44
Brown Brothers Harriman & Co
New York
$1.62M – – –
Millennium Management
45
Millennium Management
New York
$1.53M +$1.28M +25,544 New
Barclays
46
Barclays
United Kingdom
$1.5M -$87.8K -1,759 -7%
New York State Common Retirement Fund
47
New York State Common Retirement Fund
New York
$1.35M +$118K +2,362 +12%
Susquehanna International Group
48
Susquehanna International Group
Pennsylvania
$1.33M +$496K +9,925 +81%
KBC Group
49
KBC Group
Belgium
$1.3M – – –
Citigroup
50
Citigroup
New York
$1.3M +$996K +19,943 +1,151%
1
2
3 4 5

KRYS Hedge Fund Activity: Q4 2020 in Review

108 of the 5,652 institutional investors tracked by Wall St. Rank reported a position in Krystal Biotech (KRYS) for Q4 2020, worth a combined $836M — up 34% from $623M a quarter earlier.

Buyers outnumbered sellers: 20 funds opened new KRYS positions and 10 closed out — a net gain of 10 holders — while 35 added to existing stakes and 31 trimmed.

The largest buyer was BlackRock, adding an estimated $10.5M. The largest seller was Victory Capital Management, exiting entirely with an estimated $22.6M sold.

  • 108 institutional investors held Krystal Biotech (KRYS) as of Q4 2020, up from 98 in Q3 2020.
  • Funds reported $836M of Krystal Biotech stock for Q4 2020, up 34% quarter-over-quarter.
  • 20 funds opened new Krystal Biotech positions in Q4 2020 and 10 closed out, a net change of +10 holders.
  • The largest Krystal Biotech buyer in Q4 2020 was BlackRock, an estimated $10.5M added.
  • The largest Krystal Biotech seller in Q4 2020 was Victory Capital Management, an estimated $22.6M sold.

Based on aggregated 13F filings for Q4 2020.